Brain insulin action: Implications for the treatment of schizophrenia
- 15 May 2020
- journal article
- review article
- Published by Elsevier BV in Neuropharmacology
- Vol. 168, 107655
- https://doi.org/10.1016/j.neuropharm.2019.05.032
Abstract
No abstract availableFunding Information
- Centre for Addiction and Mental Health
- Physicians' Services Incorporated Foundation
This publication has 132 references indexed in Scilit:
- Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode PsychosisJAMA Psychiatry, 2013
- Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode PsychosisNeuropsychopharmacology, 2011
- Antipsychotic drugs and obesityTrends in Molecular Medicine, 2011
- Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistanceNeurobiology of Learning and Memory, 2010
- Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysisMolecular Psychiatry, 2010
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and AdolescentsJAMA, 2009
- Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male ratsEuropean Journal of Pharmacology, 2008
- Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathwayMolecular Psychiatry, 2008
- Serotonin 2C Receptor Agonists Improve Type 2 Diabetes via Melanocortin-4 Receptor Signaling PathwaysCell Metabolism, 2007
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006